PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway
文献类型：期刊论文
| 作者 | Zhang, Xiu-Ping1; Jiang, Ya-Bo1; Zhong, Cheng-Qian1; Wang, Kang1; Cheng, Shu-Qun1; Ma, Ning2; Zhang, Er-Bin2; Li, Jing-Jing2; Deng, Yue-Zhen2; Xie, Dong2 |
| 刊名 | CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
 |
| 出版日期 | 2018 |
| 卷号 | 47期号:4页码:1643-1654 |
| 关键词 | Protein arginine methyltransferase 1 Hepatocellular carcinoma STAT3 signalling pathway Cryptotanshinone |
| ISSN号 | 1015-8987 |
| DOI | 10.1159/000490983 |
| 文献子类 | Article |
| 英文摘要 | Background/Aims: Although it has been widely accepted that protein arginine methyltransferase 1 (PRMT1) is a cancer-promoting gene in various cancers, the mechanism of PRMT1 in hepatocellular carcinoma (HCC) requires more exploration. This study aimed to investigate the role of PRMT1 in HCC growth and metastasis. Methods: We compared PRMT1 expression and clinicopathological characteristics using paired HCC and adjacent noncancerous liver tissues from 210 patients and immunohistochemistry analyses. Cell proliferation, colony formation and migration were determined in HCC cell lines with PRMT1 overexpression or downregulation through MTT, crystal violet and Boyden chamber assays. Tumour growth was monitored in a xenograft model, and intrahepatic metastasis models were established. Results: PRMT1 expression was greatly increased in clinical HCC samples and strongly associated with poor prognosis and recurrence; PRMT1 expression was also positively correlated with microvascular invasion (P = 0.024), tumour differentiation (P = 0.014), tumour size (P = 0.002), and portal vein tumour thrombus (PVTT) (P = 0.028). Cell proliferation, colony formation and migration in vitro were enhanced by PRMT1 upregulation and decreased by PRMT1 downregulation in HCC cell lines. Moreover, low PRMT1 expression resulted in slow tumour growth and decreased tumour weight in vivo, as well as tumour metastasis. These phenotypes were associated with STAT3 signalling pathway activation. Cryptotanshinone, a STAT3 inhibitor, inhibited STAT3 phosphorylation and reversed the HCC phenotype of PRMT1 expression. Conclusions: We revealed a significant role for PRMT1 in HCC progression and metastasis in vitro and in vivo via STAT3 signalling pathway activation. PRMT1 may be a potential novel prognostic biomarker and new therapeutic target for HCC. (C) 2018 The Author(s) Published by S. Karger AG, Basel |
| 学科主题 | Cell Biology ; Physiology |
| WOS关键词 | PROTEIN ARGININE METHYLATION ; BREAST-CANCER CELLS ; HEPATOCELLULAR-CARCINOMA ; INHIBITION ; MIGRATION ; EXPRESSION ; MANAGEMENT ; SORAFENIB ; APOPTOSIS ; UPDATE |
| 语种 | 英语 |
| WOS记录号 | WOS:000440136200026 |
| 出版者 | KARGER |
| 版本 | 出版稿 |
| 源URL | [http://202.127.25.144/handle/331004/1026]  |
| 专题 | 中国科学院上海生命科学研究院营养科学研究所 |
| 作者单位 | 1.Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 6, Shanghai, Peoples R China; 2.Univ Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Lab Mol Oncol, Shanghai, Peoples R China; 3.Fujian Med Univ, LongYan Hosp 1, Fuzhou, Fujian, Peoples R China; 4.BinZhou Med Univ Hosp, Dept Hepat Surg, Binzhou, Peoples R China, |
| 推荐引用方式 GB/T 7714 | Zhang, Xiu-Ping,Jiang, Ya-Bo,Zhong, Cheng-Qian,et al. PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway[J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY,2018,47(4):1643-1654. |
| APA | Zhang, Xiu-Ping.,Jiang, Ya-Bo.,Zhong, Cheng-Qian.,Wang, Kang.,Cheng, Shu-Qun.,...&,.(2018).PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway.CELLULAR PHYSIOLOGY AND BIOCHEMISTRY,47(4),1643-1654. |
| MLA | Zhang, Xiu-Ping,et al."PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway".CELLULAR PHYSIOLOGY AND BIOCHEMISTRY 47.4(2018):1643-1654. |
入库方式： OAI收割
来源：上海营养与健康研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。